| Literature DB >> 34564162 |
Javier Echave1, Maria Fraga-Corral1,2, Pascual Garcia-Perez1, Jelena Popović-Djordjević3, Edina H Avdović4, Milanka Radulović5, Jianbo Xiao1,6, Miguel A Prieto1,2, Jesus Simal-Gandara1.
Abstract
Seaweeds are industrially exploited for obtaining pigments, polysaccharides, or phenolic compounds with application in diverse fields. Nevertheless, their rich composition in fiber, minerals, and proteins, has pointed them as a useful source of these components. Seaweed proteins are nutritionally valuable and include several specific enzymes, glycoproteins, cell wall-attached proteins, phycobiliproteins, lectins, or peptides. Extraction of seaweed proteins requires the application of disruptive methods due to the heterogeneous cell wall composition of each macroalgae group. Hence, non-protein molecules like phenolics or polysaccharides may also be co-extracted, affecting the extraction yield. Therefore, depending on the macroalgae and target protein characteristics, the sample pretreatment, extraction and purification techniques must be carefully chosen. Traditional methods like solid-liquid or enzyme-assisted extraction (SLE or EAE) have proven successful. However, alternative techniques as ultrasound- or microwave-assisted extraction (UAE or MAE) can be more efficient. To obtain protein hydrolysates, these proteins are subjected to hydrolyzation reactions, whether with proteases or physical or chemical treatments that disrupt the proteins native folding. These hydrolysates and derived peptides are accounted for bioactive properties, like antioxidant, anti-inflammatory, antimicrobial, or antihypertensive activities, which can be applied to different sectors. In this work, current methods and challenges for protein extraction and purification from seaweeds are addressed, focusing on their potential industrial applications in the food, cosmetic, and pharmaceutical industries.Entities:
Keywords: bioactive peptides; extraction; industrial application; protein; seaweed
Mesh:
Substances:
Year: 2021 PMID: 34564162 PMCID: PMC8471739 DOI: 10.3390/md19090500
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Average protein content, essential amino acidic composition, and digestibility of few representative seaweed sources.
| Species | Protein | EAA Composition | EAA | Digestibility | Reference |
|---|---|---|---|---|---|
|
| |||||
|
| 31–45% | R 1.3, H 0.2, K 1.6, T 1.7, I 2.3, L 1.9, V 3.1, M 0.2, F 1.7, C 0.4, P 1.0, A 1.9, Y 1.3, D 2.6, E 2.4, G 1.1, S 1.6 | 14% | 68% (in vivo) | [ |
|
| 55% | T 4.1, V 5.4, M 2.0, I 4.3, L 7.2, K 5.7, F 4.7, W 0.9, H 1.7, S 6.2, Q + E 14.9, P 7.9, G 5.8, A 8.8, C 2.5, D + N 9.7, Y 2.7, R 5.6 | 36% | 56% (pancreatin) | [ |
| 31% | D 8.5, T 5.3, S 4.9, E 10.2, G 5.1, A 6.2, V 5.2, I 3.3, L 5.9, Y 3.4, F 3.5, H 2.6, K 5.2, R 5.9, P 3.6, C 1.3, M 1.8, W 0.7 | 51% | 57% (pepsin), | [ | |
|
| |||||
|
| 12% | A 5.5, R 6.5, N 15.3, E 15.3, G 6.7, H 1.4, I 3.6, L 7.0, K 7.4, M 1.8, F 4.5, P 5.7, S 4.3, T 5.1, Y 4.3, V 5.8 | 13.9% | N.A. | [ |
|
| 11% | D 0.8, E 1.1, S 0.5, H 0.1, G 0.5, T 0.6, R 0.4, A 0.6, Y 0.4, V 1.4, M 0.9, C 0.1, I 0.4, L 0.7, F 0.5, L 0.5 | 5.4% | N.A. | [ |
| 27% | D 1.5, E 1.5, S 0.8, H 0.1, G 0.8, T 0.8, R 0.5, A 1.1, Y 0.4, V 0.3, M 0.7, I 0.5, L 1.0, F 1.2, K 0.7 | 12% | 17% (pepsin), | [ | |
|
| |||||
|
| 4% | A 6.8, R 4.4, N 14.0, E 1596, G 5.8, H 1.7, I 4.0, L 6.8, K 5.5, M 1.9, F 5.0, P 4.0, S 5.6, T 5.5, Y 3.7, V 5.6 | 4.6% | N.A. | [ |
|
| 12% | D 9.1, T 4.1, S 5.6, E 18.7, G 4.8, A 4.3, V 4.9, I 4.0, L 6.7, Y 2.8, F 4.6, H 2.6, K 3.1, R 4.5, P 3.8, C 0.9, M 1.6, W 0.4 | 10.9% | N.A. | [ |
|
| 19.8% | D 8.7, T 4.4, S 4.0, E 14.5, G 5.1, A 4.7, V 5.2, I 4.1, L 7.4, Y 2.9, F 4.7, H 2.5, K 5.6, R 5.2, P 3.6, C 0.9, M 1.7, W 0.7 | 35.5% | 24% (pepsin), 48% (pancreatin), 87% (pronase) | [ |
Abbreviations: dw: Dry weight, N.A: Not analyzed, prot: Protein, EAA: Essential amino acids, TAA: Total amino acids.
Source, protein yield, pre-treatment, extraction, and purification methods described. Protein yields are indicated as % of algal biomass dw.
| Source | Pretreatment | Extraction Method | Precipitation and Purification | Yield | Reference |
|---|---|---|---|---|---|
|
| |||||
|
| Freeze-dried | SLE ak, 0.12 M NaOH + 0.1 mg/L NAC, 1 h, 25 °C | Pr: IP, pH 4, 1N HCl | 11.57% | [ |
| Freeze dried | EAE (E:S 0.5) Celluclast 0.2% + Alcalase 0.2%, pH 4.5, 14 h, 50 °C // SLE ak, 0.1 M NaOH + 1 g/L NAC, 1.5 h, 25 °C | Pr: IP, pH 3, 5M HCl | 13.7% | [ | |
| Dried, milled | EAE-HHPE, Hemicellulase (E:S 0.05), pH 4.5, 400 MPa, 20 min 40 °C | - | 6.3% | [ | |
|
| Dried, milled | EAE-HHPE, Hemicellulase (E:S 0.05), pH 4.5, 400 MPa, 20 min, 40 °C | - | 3.4% | [ |
|
| Freeze dried | SLE ak, NaOH 0.12 M, 1 h, 25 °C | Pr: IP, pH 4.5 1M HCl | 14.28% | [ |
|
| Freeze dried | UAE ak, 400 W, 40 kHz, 0.01% NaOH, 20 min, 35 °C | Pr: (NH4)2SO4, 40%, 4 h, 4 °C | 3.8% | [ |
|
| Freeze dried | UAE, dW (1:20), 42 Hz, 1 h, 4 °C | Pr: (NH4)2SO4, 80%, 1 h, 4 °C | ~6.7% | [ |
| Freeze dried | HHPE, dW (1:20) 600 MPa, 4 min, 4 °C | Pu: Filtered, 100 μm nylon bag | ~3.1% | ||
|
| Oven dried (60 °C) | EAE Cellic CTec3 (E:S 0.1, 1.64 U/mg), pH 4.5, 16 h, 50 °C | Pr: Cold acetone (1: 4), 2 h | 6.35% | [ |
|
| |||||
| Oven dried (60 °C), freeze dried, milled | UAE ak (2×), (1:10), 1M NaOH, sonication (Hz non specified), 2 h, 25 °C | Pu: Filtered (0.45 μm) // DI, 2 kDa // IEC, Tris buffer, pH 9.5 // DI 2 kDa | 5.4% | [ | |
| Freeze dried, milled | SLE (1:20), lysis solution (8 M urea, 2% Tween, 1% PVP, 30 mM DTT), 16 h, 4 °C | Pu: DI, 6–8 kDa, 4 °C, 16 h | 11.88% | [ | |
| Untreated | PFE aq, dW, 50 kV, 50 pulses, 0.5 Hz, 34 kJ // Mechanical press | Pr: DI, 100–500 kDa | 4.7% | [ | |
|
| Oven dried (55 °C), milled | SLE aq, dW (1: 20), 16 h, 30 °C // SLE 1M NaOH, pH 12, 30 °C, 2 h | Pr: IP, pH 2.25, 10% | 12.28% | [ |
| Fresh, pulped | SLE aq, dW (1:20), 16 h, 30 °C // Filtration (100 μm) // SLE 1M NaOH, pH 12, 30 °C, 2 h // Filtration (100 μm) | Pr: IP, pH 2.25, 10% | 17.13% | ||
| OS (1:10), 30 min, 40 °C // 0.05M HCl, 1 h, 85 °C | MAE aq, dW (1:34), 5 min., 123 °C | Pr: IP, pH 2.25, 10% | 11.3% | [ | |
|
| Oven dried (60 °C), milled | SLE ak, 1M NaOH, pH 12 + 0.5% 2-mercaptoethanol, 2 h, 25 °C | Pr: (NH4)2SO4 80% | 6.48% | [ |
|
| |||||
|
| Oven dried (40 °C) | SLE ak (1:15) 0.4M NaOH 1 h, 4°C // SLE ac (1:15) 0.4M HCl 1 h, 4 °C | Pu: HPSEC, 150–300 Å, 15 min, 40 °C | 4.23% | [ |
|
| Freeze dried, milled | HAE aq Autoclave, dW (1:20), 0.101 MPa, 2 × 15 min, 124 °C | Pu: Filtered, 100 μm muslin bag | ~2.4% | [ |
|
| Freeze dried | SLE ak, 1M NaOH, pH 12 + 0.5% 2-mercaptoethanol, 2 h, 25 °C | Pr: (NH4)2SO4 85% | 8.2% | [ |
|
| Oven dried (60 °C) | EAE Cellic CTec3 (E:S 0.1, 1.64 U/mg), pH 4.5, 16 h, 50 °C | Pr: Cold acetone (1:4), 2 h | 7.39% | [ |
|
| Dried, powdered | SLE aq, dW (1:3), 20 min, 93 °C | Pu: HPLC, Develosil ODS-5 column, 25% CH3CN + 0.05% CF3COOH | 12% | [ |
|
| Freeze dried, milled | UAE aq, dW (1:20), 42 Hz, 1 h, 4 °C | Pr: (NH4)2SO4, 80%, 1 h, 4 °C | ~1.8% | [ |
Abbreviations: OS: Osmotic shock, EPr: Enzymatic pretreatment, Upr: Ultrasonic treatment, //: sequential procedures, SLE: Solid-liquid extraction, aq: Aquose, ak: Alkaline, ac: Acid, Pr: Precipitation, Pu: Purification, dW: Deionized water, DI: Dialysis, NAC: N-acetyl-L-cysteine, EAE: Enzyme-assisted extraction, UAE: Ultrasound-assisted extraction, HHPE: High hydrostatic pressure extraction, PEF: Pulse-electric field, PBS: Sodium phosphate buffer, PVP: polyvinyl propylene, DTT: dithiothretol, IEC: Ionic exchange chromatography, HPSEC: High performance size exclusion chromatography, IP: Isoelectric precipitation. n.s.: Not stated.
Figure 1Depiction of ultrafiltration, ionic exchange chromatography and dialysis in protein purification.
Figure 2Schematic depiction of production of SP hydrolysates and bioactive peptides (BAPs) from seaweed. Proteins are extracted from seaweed cells and subsequently hydrolyzed in a single (1a) or multiple steps (1b and 2) to produce a protein hydrolysate. The protein hydrolysate is further separated into peptide fractions using diverse purification methods.
Bioactive SP-derived hydrolysates, peptides, aminoacidic sequence of bioactive peptides, and proteolytic methods used.
| Seaweed | Hydrolysis Method | Peptide Sequence | Bioactivity Reported | Reference |
|---|---|---|---|---|
|
| ||||
|
| Papain, (E:S 20.7), pH 6, 24 h, 60 °C | IRLIIVLMPILMA, NIGK, IR | Renin, DPP IV, PAF-AH inhibition | [ |
| Corolase PP (E:S 1), pH 7, 2 h, 50 °C | ILAP, LLAP, MAGVDHI, FITDGNK., NAATIIK, ANAATIIK, SDITRPGGQM, DNIQGITKPA., LITGA., LITGAA., LITGAAQA., LGLSGK., LTLAPK, LTIAPK, ITLAPK ITIAPK, VVPT, QARGAAQA | Antioxidant, DPP IV inhibition | [ | |
|
| Fungal protease concentrate (E: S 5) pH 4.3, 3 h, 55 // Flavourzyme (E:S 2), pH 7, 4 h, 55 °C | N.A. | Antitumor, anti-inflammatory, antioxidant | [ |
|
| Pepsin (E:S 0.025), 5 h, 45 °C | NMEKGSSSVVSSRM | Anticoagulant | [ |
|
| Alcalase + Flavourzyme (E:S 1), pH 7, 4 h, 50 °C | DYYLR, AGFY, YLVA, AFIT, SFLPDLTDQ, MKTPITE, TYIA, LDLW | ACE, DPP IV inhibition | [ |
| Prolyve 1000, (E:S 1), 2 h, 50 °C | N.A. (higher < 1 kDa peptides proportion) | Antioxidant | [ | |
| Pepsin (E:S 8), pH 2, 4 h, 37 °C | GGSK, ELS | α-amylase inhibition | [ | |
|
| Thermolysin (E:S 1), pH 7, 5 h, 37 °C | YRD, VSEGLD, TIMPHPR, GGPAT, SSNDYPI, SRIYNVKSNG, VDAHY, YGDPDHY, NLGN, DFGVPGHEP | ACE inhibition | [ |
|
| α-chymotrypsin (E:S 4), pH 8, 2 h, 37 °C | ELWKTF | Antioxidant | [ |
| Trypsin (E:S 4), pH 8, 8 h, 37 °C | QVEY | ACE inhibition | [ | |
|
| ||||
| Alcalase (E:S 5), pH 7.6, 90 min, 25 °C // 10 min, 100 °C | PAFG | ACE inhibition | [ | |
|
| Trypsin + Pepsin + Papain (E:S 4), pH 8.42, 5 h, 28.5 °C | FGMPLDR, MELVLR | ACE inhibition | [ |
|
| Pepsin (E:S 1), pH 2, 20 h, 37 °C // Bromelain (E:S 1), pH 7, 20 h, 37 °C | IP, AFL | ACE, Renin inhibition | [ |
|
| Papain (E:S 1), pH 6, 24 h, 60 °C | Total of 58 non-allergenic, ACE inhibitory peptides identified | ACE inhibition | [ |
| Purazyme + Flavourzyme // Alkaline protease-Protex 6L + Flavourzyme | N.A. | Anti-inflammatory (IL10 expression & TNF-α inhibition) | [ | |
|
| ||||
|
| Pepsin (80 U/g S), pH 2, 2 h, 37 °C // Papain (60 U/g S), pH 7, 3 h, 50 °C | RVLSAAFNTR, IMNILEK, GGVQAIR, KAALMEK, GVFDGPCGT, SGVFDGPCGT, QNIGDPR, AYSSGVSFK, RWDISQPY, LVYIVQGR, KPGGSGR, LGLSAKNYGR, KEAWLIEK, REVADDK, ENFFFAGIDK, QEMVDK, EEEEEEQQQ | Antyhypertensive (ACE & ET-1 inhibition) | [ |
|
| Protease S “Amano” (E:S 0.01), pH 8, 18 h, 70 °C | VY, IY, AW, FY, VW, IW, LW | Antihypertensive (ACE inhibition & in vivo) | [ |
| dW (3:20), 20 min, 93 °C | YH, KY, FY, IY | Antihypertensive (ACE inhibition & in vivo) | [ | |
|
| Trypsin (E:S 0.05), pH 7, 24 h, 30 °C | TITLDVEPSDTIDGVK, ISGLIYEETR, MALSSLPR, ILVLQSNQIR, ISAILPSR, IGNGGELPR, LPDAALNR, EAESSLTGGNGCAK, QVHPDTGISK | Antimicrobial | [ |
|
| Alcalase + Papain + Trypsin (E:S n.s.), time n.s., pH 7.5, 55 °C | KY, GKY, STKY, AKY, AKYSY, KKFY, FY, KFKY | ACE inhibition | [ |
Abbreviations: //, Subsequent procedures; n.s., Not stated; N.A.: Not analyzed; DPP, Dipeptidyl peptidase; PAF-AH, Platelet activating factor acetylhydrolase; ACE, Angiotensin 1 converter enzyme; ET-I, Endothelin-1; dW, Deionized Water.
Figure 3Reported bioactivities of different seaweed biomolecules with potential industrial application.